Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXX5QC
|
||||
| Drug Name |
4-methyl-3-(3-(4-(methylamino)-1,3,5-triazin-2-yl)pyridin-2-yloxy)-N-(3-(trifluoromethyl)phenyl)benzamide
|
||||
| Synonyms |
CHEMBL426211
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C24H19F3N6O2
|
||||
| Canonical SMILES |
CNc1ncnc(n1)c2cccnc2Oc3cc(ccc3C)C(=O)Nc4cccc(c4)C(F)(F)F
|
||||
| InChI |
InChI=1S/C24H19F3N6O2/c1-14-8-9-15(21(34)32-17-6-3-5-16(12-17)24(25,26)27)11-19(14)35-22-18(7-4-10-29-22)20-30-13-31-23(28-2)33-20/h3-13H,1-2H3,(H,32,34)(H,28,30,31,33)
|
||||
| InChIKey |
AQJFXYZAOCPIBG-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Angiopoietin 1 receptor | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling PathwayNetPath_8:Wnt Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathwayP00005:Angiogenesis | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY networkangiopoietinreceptor_pathway:Angiopoietin receptor Tie2-mediated signaling | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.